YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Stocks rise broadly; Pfizer gains after FDA approves vaccine

Posted online

Pfizer stock rose 2.5% Monday after the Food and Drug Administration gave full approval to its COVID-19 vaccine.

The increase was among moves to push the Nasdaq composite to an all-time high and help the S&P 500 more than make up for its losses last week.

Technology, communication and financial stocks also rose on Wall Street, and energy stocks rallied as the price of U.S. crude oil jumped 5.3%, according to U.S. News.

Read more from U.S. News & World Report.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences